Products

TickDoc

AI-native

Documenting tickets is a chore. So it gets skipped.

tickdoc.net Writing & Documents / AI Writing Assistants

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$79/mo
Higher than 94% of peersNiche median $12/mo
Creators
Peonixo
No social account linked
Launched
7mo ago
2026-04-22 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    The AI toolkit built for IT support technicians

    Apr 22 · 7mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-04-18

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Starter
Freeforever
Pro
$79/mo
$79 base + $39 per additional user · First user included · up to 50 seats

Trial: None · 1 paid tier ($79) · Observed 2026-11-07 · Source page

Entry price $79/mo, Higher than 94% of peers; “AI Writing Assistants” median is $12/mo.View pricing benchmark

Website snapshots

Indexed 2026-04-22

Key pages

Desktop & mobile archive
Home
tickdoc.net/ Snapshot 2026-11-07

Questions & evidence

How much does TickDoc cost?
Starter: Freeforever; Pro: $79/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does TickDoc get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is TickDoc and what platforms does it support?
TickDoc is catalogued under AI Writing Assistants: Documenting tickets is a chore. So it gets skipped. Supported platforms: Web.

Related products in this category

Writing & Documents / AI Writing Assistants

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.